JBCHEPHARM
₹1729.6-18.8 (-1.08%)
Quarterly ResultsProfit & LossBalance SheetCash Flow
Key Insights
POSITIVE
- Operating margin improved continuously, reaching 23.29% in Q406, signaling effective cost management.
- Despite a marginal decline in sales, net profit remained robust, reflecting operational efficiencies.
- Other income showed an increase in Q503, providing an additional buffer to overall profitability.
NEGATIVE
- Company experienced a cash flow shortfall with a 10% decrease this year [Dummy Data]
- Company’s strategic partnerships have yet to generate expected growth. [Dummy Data]
- Company’s EBITDA shrank at a CAGR of -8% over the past 3 years. [Dummy Data]
Quarterly Results Data
| Field | Trend | Dec 23 | Mar 24 | Jun 24 | Sep 24 | Dec 24 | Mar 25 | Jun 25 | Sep 25 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 844.51 | 861.73 | 1,004.40 | 1,000.62 | 963.49 | 949.48 | 1,093.94 | 1,084.90 | |
| Expenses | 667.91 | 713.76 | 770.45 | 774.04 | 753.50 | 770.93 | 836.88 | 821.09 | |
| Operating Profit | 176.60 | 147.97 | 233.95 | 226.58 | 209.99 | 178.55 | 257.06 | 263.81 | |
| Other Income | 7.35 | 16.63 | 5.89 | 9.95 | 8 | 14.48 | 14.55 | 15.34 | |
| Interest | 12.49 | 9.41 | 5.64 | 2.06 | 2.58 | 1.45 | 1.11 | 1.35 | |
| Depreciation | 34.03 | 40.74 | 40.78 | 41.88 | 41.94 | 46.44 | 42.70 | 44.44 | |
| Profit Before Tax | 183.95 | 164.60 | 239.84 | 236.53 | 217.99 | 193.03 | 271.61 | 279.15 | |
| Tax | 50.38 | 38.44 | 63.01 | 61.96 | 55.50 | 47.34 | 69.23 | 71.33 | |
| Net Profit | 133.57 | 126.16 | 176.83 | 174.57 | 162.49 | 145.69 | 202.38 | 207.82 | |
| EPS in Rs | 8.62 | 8.22 | 11.39 | 11.24 | 10.46 | 9.36 | 12.99 | 13.29 |